Sanofi partners with AI firm Exscientia to develop up to 15 new drugs Medical Dialogues Bureau8 Jan 2022 3:00 PM ISTNew Delhi: French drugmaker Sanofi SA (SASY.PA) will partner with British AI firm Exscientia Plc (EXAI.O) to develop up to 15 drug candidates across...
French court backs class action against Sanofi over Depakine drug Medical Dialogues Bureau6 Jan 2022 11:52 AM ISTPARIS: A French court ruled on Wednesday that families of victims of Depakine, an epilepsy drug that caused birth defects and learning difficulties...
Lawsuit accusing Sanofi, Eli Lilly of scheming to inflate drugs' prices pared down Ruchika Sharma20 Dec 2021 2:33 PM ISTNew Delhi: A federal judge on Friday pared down a class action lawsuit brought by consumers accusing three of the biggest makers of diabetes drugs,...
Sanofi to acquire Origimm Biotechnology Ruchika Sharma1 Dec 2021 11:30 AM ISTParis: Sanofi announced today it entered into an agreement to acquire Origimm Biotechnology GmbH, an Austrian privately owned biotechnology company...
Sanofi wins second chemotherapy drug Taxotere bellwether trial verdict Medical Dialogues Bureau22 Nov 2021 12:00 PM ISTNew Delhi: Sanofi provided sufficient warning to a Louisiana woman that its chemotherapy drug Taxotere could cause permanent hair loss, a jury found...
Sanofi invests USD 180 million equity in Owkin to advance oncology pipeline Ruchika Sharma22 Nov 2021 10:00 AM ISTParis: Sanofi has announced an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development...
Sanofi to invest up to Rs 445 crore in Gyroscope Therapeutics Ruchika Sharma10 Nov 2021 11:30 AM ISTLondon: Gyroscope Therapeutics Holdings plc has recently announced that Sanofi, a global biopharmaceutical company, has committed to invest up to...
Sanofi drops plans for mRNA Covid-19 vaccine amid BioNTech-Pfizer, Moderna success Ruchika Sharma30 Sept 2021 1:26 PM ISTParis: Sanofi is dropping plans for its own mRNA-based Covid-19 vaccine because of the dominant role of the BioNTech-Pfizer alliance as well as...
Sanofi Rilzabrutinib phase 3 trial for Pemphigus treatment fails to meet endpoints Ruchika Sharma11 Sept 2021 4:08 PM ISTParis: In a setback to Sanofi, the Phase 3 PEGASUS trial evaluating rilzabrutinib to treat pemphigus, a rare autoimmune skin condition, did not meet...
Sanofi India to transfer Nutraceuticals business to Universal Nutriscience Ruchika Sharma29 July 2021 1:18 PM IST16 nutraceutical brands in the portfolio would be transferred to Universal Nutriscience as part of the transaction.
Suit over chemotherapy drug Taxotere: Sanofi loses bid for summary judgment in 2nd bellwether trial Ruchika Sharma17 July 2021 6:06 PM ISTNew Delhi: Sanofi has lost a bid for summary judgment in the second bellwether case in multidistrict litigation over its chemotherapy drug Taxotere,...
Sanofi-Regeneron first-line cancer treatment Libtayo gets European nod Ruchika Sharma26 Jun 2021 4:09 PM ISTParis: The European Commission (EC) has approved Sanofi and Regeneron's PD-1 inhibitor Libtayo (cemiplimab) for the first-line treatment of adults...
